Jane Street’s ABVC BioPharma ABVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-10,700
Closed -$10.4K – 11395
2026
Q1
$10.4K Buy
+10,700
New +$17.7K ﹤0.01% 11300

Other funds holding ABVC

Jane Street's ABVC Position: Q3 2026 in Review

Jane Street sold out of ABVC BioPharma (ABVC) in Q3 2026, closing a stake of 20,059 shares — an estimated $31.7K sold.

Jane Street first reported a position in ABVC in Q3 2022 and held it in 3 quarters. The position peaked at $31.7K in Q2 2026. 11 funds tracked by Wall St. Rank hold ABVC as of Q3 2026.

  • Jane Street reported no remaining ABVC BioPharma position as of Q3 2026 after selling out during the quarter.
  • Jane Street sold 20,059 ABVC BioPharma shares in Q3 2026, an estimated $31.7K.
  • Jane Street first reported a position in ABVC BioPharma in Q3 2022 and held it in 3 quarters.
  • Jane Street's ABVC BioPharma position peaked at $31.7K in Q2 2026.
  • 11 funds tracked by Wall St. Rank held ABVC BioPharma as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.